2004年至2024年癌症中蛋白质棕化研究趋势:2004年至2024年癌症中蛋白质棕化研究趋势:2004年至2024年癌症中蛋白质棕化研究趋势:2004年至2024年癌症中蛋白质棕化研究研究趋势:2024年癌症中蛋白质棕化研究趋势:2
Yufeng Peng1, Kewei Peng2, Yi Wang1
1Department of Oncology, Zhenhai Hospital of Traditional Chinese Medicine, Ningbo, China.
Frontiers in oncology
|July 8, 2025
概括
蛋白棕化在癌症研究中越来越多地受到研究. 这份对685篇论文的图书统计分析显示,人们越来越关注其在瘤免疫逃避,代谢重编程和治疗策略中的作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 蛋白质棕化,是一种可逆的脂质修饰,涉及将棕酸附着在囊氨酸残留物上.
- 这种修改会影响蛋白质的疏水性,膜局部化,稳定性和功能.
- 棕化越来越多地被认为对癌症的发展和进展起着重要的作用.
研究的目的:
- 对蛋白质棕化和癌症的研究进行系统的参考资料分析.
- 确定该领域的出版趋势,研究热点和合作网络.
- 评估癌症生物学中对蛋白质棕代谢的科学调查的动态.
主要方法:
- 使用网络科学核心收藏 (WoSCC) 进行系统的文献计量分析.
- 2004年至2024年间出版的685篇论文的精选.
- 提取和分析出版物数据,包括标题,摘要和关键词.
主要成果:
- 从2004年到2024年,共发表了685篇关于蛋白质棕化和癌症的论文,在2020年后显著增加.
- 美国和中国是领先的国家,哈佛大学和中国科学院是关键机构.
- 研究重点已经转向癌症特定的应用,包括瘤免疫逃避,代谢重编程和治疗策略.
结论:
- 未来的研究应该优先考虑为特定亚型的模式创建泛癌棕化部位地图.
- 开发针对ZDHHC酶的亚型选择性抑制剂对于克服当前的毒性问题至关重要.
- 建立国际研究合作关系可以将基础研究和临床创新联系起来,用于精密治疗.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Covalently Linked Protein Regulators
7.3K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.3K
Protein Kinases and Phosphatases
13.5K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.5K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Proteasome
9.1K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.1K


